Fabry disease and renal and urological diseases
Conditions
Interventions
None listed
Sponsors
Niigata University of Health and Welfar
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were suspected of having glomerulonephritis, diabetic nephropathy, or malignant tumors of the renal or urinary tract during outpatient visits at collaborating or partner research institutions, and who provided informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients whose remaining sample volume is insufficient for the measurements required in this study, or who are otherwise deemed unsuitable for participation by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The establishment of a clinically meaningful diagnostic approach enables early detection, diagnosis, and treatment of nephrological and urological disorders, thereby contributing to the reduction of new dialysis initiations and overall healthcare expenditures. | — |
Countries
Japan
Contacts
Public ContactTAKASHI YOKOYAMA
Niigata University of Health and Welfar Department of Clinical Engineerring, Faculty of Medical Technology
Outcome results
None listed